Drug-labels.com

Ruzurgi: Uses, Side Effects and Dosage

Updated:
Facts
Status:
Prescription (Rx)
Strength:
10 mg
Active ingredient:

Patient Medication Information: uses, side effects, how to take - Ruzurgi

What is Ruzurgi used for?

Ruzurgi is used to treat the symptoms of Lambert-Eaton myasthenic syndrome (LEMS) in patients 6 years of age and older. It is not known if Ruzurgi works or is safe in children less than 6 years old.

How does Ruzurgi work?

The way that Ruzurgi works in patients with LEMS is not fully understood.

What are the ingredients in Ruzurgi?

Medicinal ingredients: amifampridine.

Non-medicinal ingredients (listed in alphabetical order): colloidal silicon dioxide, dibasic calcium phosphate dihydrate, magnesium stearate, microcrystalline cellulose and sodium starch glycolate.

Ruzurgi comes in the following dosage forms:

10 mg tablets

Do not use Ruzurgi if:

  • You are allergic to Ruzurgi or any of its ingredients
  • You have ever had a seizure (convulsion)
  • You are taking other forms of amifampridine or other aminopyridines

To help avoid side effects and ensure proper use, talk to your healthcare professional before you take Ruzurgi. Talk about any health conditions or problems you may have, including if you:

  • Have a known gene that may reduce your ability to break down a drug
  • Have kidney problems
  • Have liver problems
  • Have ever had a seizure
  • Are pregnant or planning to become pregnant.

    • It is not known if Ruzurgi can harm your unborn baby.
    • You and your healthcare professional will decide if you should take Ruzurgi if you are pregnant.
    • If you are a woman of child bearing potential you must use effective birth control during your treatment with RUZURGI.
  • Are breastfeeding or plan to breastfeed. It is not known if Ruzurgi passes into your breast milk. Talk to your healthcare professional about the best way to feed your baby while taking Ruzurgi.

Other warnings you should know about:

  • RUZURGI can cause problems with your heart rhythm called QTc prolongation, particularly if you have a known gene that may reduce your ability to break down RUZURGI. You may have no symptoms or you may have dizziness, feeling like your heart has skipped or added a beat, fainting or seizures. If these symptoms continue, they can lead to sudden death. You may be more at risk if you have had or have:

    • a heart attack
    • congestive heart failure
    • an irregular heartbeat or heart rhythm
    • a blockage in one or more of your arteries that affects blood flow to your heart
    • an abnormally rapid heart rate
    • heart palpitations (feeling like your heart has skipped a beat or added an extra beat)
    • a family history of sudden cardiac death at less than 50 years of age
    • problems of electrocardiogram (ECG) abnormality called “Long QT syndrome”
    • diabetes
    • imbalances in the electrolytes in your body (potassium, magnesium and calcium)

Tell your healthcare professional about all the medicines you take, including any drugs, vitamins, minerals, natural supplements or alternative medicines.

The following may interact with Ruzurgi:

  • Drugs that can interfere with transmission between nerves and muscles, such as pyridostigmine
  • Drugs that are known to increase the risk of seizures
  • Drugs that can affect the levels of electrolytes (potassium, magnesium and calcium) in your body:

    • Diuretics
    • Laxatives and enemas
    • Certain antibiotics
    • High doses of steroids
  • Certain drugs that have an effect on your heart rate, such as:

    • Antiarrhythmics (such as flecainide and propafenone)
    • Antipsychotics (such as chlorpromazine and haloperidol)
    • Antidepressants (such as fluoxetine and amitriptyline)
    • Opioids (such as methadone)
    • Some antibiotics (such as erythromycin, clarithromycin and ciprofloxacin)
    • Antimalarials (such as quinone and chloroquine)
    • Antifungals (such as ketoconazole)
    • Kinase inhibitors (such as sunitinib)
    • Histone deacetylase inhibitors (such as vorinostat)
    • Beta-2 adrenoceptor agonists (such as salmeterol)

How to take Ruzurgi:

  • Take Ruzurgi exactly how your healthcare professional tells you to take it
  • Do not change your dose of Ruzurgi
  • Do not stop taking Ruzurgi without first talking to your healthcare professional
  • Ruzurgi can be taken with or without food. Taking RUZURGI with food may help if you have side effects of pain in your stomach, tingling in various parts of your body or nausea.

  • Ruzurgi tablets can be cut in half if less than a full tablet is needed for you to get the right dose
  • If you require less than half of a tablet to reach your prescribed dose, have difficulty swallowing tablets, or require a feeding tube, you can prepare a 1 mg/mL suspension by following the instructions below:

You will need:

Do not use any foods or liquids other than sterile water to mix Ruzurgi.

Procedure for making a 1 mg/mL suspension (10 mL) if you require 10 mg OR LESS for each dose:

Procedure for making a 1 mg/mL suspension (30 mL) if you require MORE than 10 mg for each dose:

Prepare fresh suspensions every day. Refrigerate the suspension between uses and shake well before taking your dose. Discard any unused suspension after 24 hours.

Procedure for taking Ruzurgi by mouth:

Procedure for taking Ruzurgi through a feeding tube:

Use only an oral syringe with a catheter tip. Talk to your healthcare professional about the size and the type of catheter you should use.

Usual Dose:

  • Your dose will be decided by your doctor based on your condition and how you react to RUZURGI.
  • You will likely take RUZURGI 2 to 3 times a day and up to 5 times a day.

Overdose:

If you think you have taken too much Ruzurgi, contact your healthcare professional, hospital emergency department or regional poison control centre immediately, even if there are no symptoms.

Missed Dose:

If you miss your dose by a few hours and you are feeling weak, take your missed dose as soon as possible. If you missed your dose and it is close to your next dose, take it at your next dose. Do not double your dose to make up for the missed dose.

What are possible side effects from using Ruzurgi?

These are not all the possible side effects you may feel when taking Ruzurgi. If you experience any side effects not listed here, contact your healthcare professional.

The most common side effects of Ruzurgi are:

  • Tingling around the mouth, tongue, face, fingers, toes, and other body parts
  • Change in sense of taste (numbness or tingling in the mouth, on the lips or tongue)
  • Change or reduction in sense of touch (numbness or tingling in the fingers)
  • Stomach pain
  • Indigestion
  • Dizziness
  • Nausea
  • Diarrhea

Serious Side Effects and What to do About Them

Symptom / effectTalk to your healthcare professionalStop taking drug and get immediate medical help
Only if severeIn all cases

COMMON

Seizures

✓

UNCOMMON

Hypersensitivity reaction:

rash, itchiness along with difficulty breathing with or without swelling of the face, lips, tongue and throat.

✓

If you have a troublesome symptom or side effect that is not listed here or becomes bad enough to interfere with your daily activities, talk to your healthcare professional.

Reporting Side Effects

You can report any suspected side effects associated with the use of health products to Health Canada by:

  • Visiting the Web page on Adverse Reaction Reporting (https://www.canada.ca/en/health-canada/services/drugs-health-products/medeffect-canada/adverse-reaction-reporting.html) for information on how to report online, by mail or by fax; or
  • Calling toll-free at 1-866-234-2345.

NOTE: Contact your health professional if you need information about how to manage your side effects. The Canada Vigilance Program does not provide medical advice.

Storage:

Store Ruzurgi in the container from the pharmacy at room temperature between 20°C to 25°C for up to 3 months. Protect from moisture.

Refrigerate prepared Ruzurgi oral suspension between doses for up to 24 hours. Discard any unused portion of the suspension after 24 hours.

Keep out of reach and sight of children.

If you want more information about Ruzurgi:

  • Talk to your healthcare professional
  • Find the full product monograph that is prepared for healthcare professionals and includes this Patient Medication Information by visiting the Health Canada website (https://health-products.canada.ca/dpd-bdpp/index-eng.jsp); the manufacturer’s website (https://www.medunikcanada.com/en/), or by calling 1-855-633-8645.

Last Revised: August 5, 2020

About this document

Source: Health Canada – Drug Product Database (DPD) and product monographs · DIN (Drug Identification Number): 02503034

Revision date stated in the text: August 5, 2020

Found a mistake? Write to us via the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Drug information for Ruzurgi

Rx or OTC
Prescription (Rx)?
DIN 02503034
Schedule(s) PRESCRIPTION
Active ingredient(s) Amifampridine 10 MG
Dosage form(s) Tablet
Route(s) of administration Oral
Drug class (WHO ATC)
  1. N Nervous system drugs
    1. N07 Other nervous system drugs
      1. N07X Other nervous system drugs
        1. N07XX Other nervous system drugs
          1. N07XX05 Amifampridine
Company MEDUNIK CANADA
Current status Marketed
Current status date January 24, 2023

Source: Health Canada – Drug Product Database (DPD) and product monographs, data as of November 1, 2026. Data from the Health Canada Drug Product Database, as published there. Not a substitute for the advice of a doctor or pharmacist.